JPRN-UMIN000026134招募中未知
oMARIgliptin once A week dpp-4 inhibitor post-marketinG surveillance on safety and Efficacy - MARIAGE
MSDK.K.0 个研究点目标入组 3,000 人开始时间: 2017年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
Study of OmarigliptiN, Weekly DPP-4 inhibitor, to evaluate the effect on psychological Attitudes and Responses compared with Daily DPP-4 inhibitors in patients with type 2 diabetes mellitusJPRN-jRCTs031200437Akai Hiroaki216
尚未招募
4 期
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshType2diabetesNCT06449235Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders938
尚未招募
不适用
DPP-4(Dipeptidyl peptidase-4) inhibitor Sitagliptin Phosphate Hydrate study to the inhibition of extension atherosclerosisType2 diabetes mellitus (borderline)JPRN-UMIN000004881Tokushima University Hospital40
已完成
不适用
The Effects of 6-Month DPP-4 inhibitor Treatment in Diabetic Patients during Oral Glucocorticoids AdministratioDiabetesJPRN-UMIN000014508ational Center for Global Health and Medicine, Kohnodai Hospital50
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30